![](https://webarchive.library.unt.edu/web/20090115060853im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/web/20090115060853im_/http://www.cancer.gov/images/spacer.gif)
cannabis-based oromucosal spray GW-1000-02 An herbal preparation containing a defined quantity of specific cannabinoids formulated for oromucosal spray administration with potential analgesic activity. Cannabis-based oromucosal spray GW-1000-02 contains a standardized extract of tetrahydrocannabinol (THC), the non-psychoactive cannabinoid cannabidiol (CBD), other minor cannabinoids, flavonoids, and terpenes from two cannabis plant varieties. Cannabinoids interact with G protein-coupled cannabinoid 1 (CB1) receptors in the central nervous system, resulting in analgesic, euphoric, and anticonvulsive effects.
Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/web/20090115060853im_/http://www.cancer.gov/images/spacer.gif)
Foreign brand name: | ![](https://webarchive.library.unt.edu/web/20090115060853im_/http://www.cancer.gov/images/spacer.gif) | Sativex | | ![](https://webarchive.library.unt.edu/web/20090115060853im_/http://www.cancer.gov/images/spacer.gif) | Code name: | ![](https://webarchive.library.unt.edu/web/20090115060853im_/http://www.cancer.gov/images/spacer.gif) | GW-1000-02 | | ![](https://webarchive.library.unt.edu/web/20090115060853im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/web/20090115060853im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/web/20090115060853im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/web/20090115060853im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/web/20090115060853im_/http://www.cancer.gov/images/spacer.gif) |